241 related articles for article (PubMed ID: 31067463)
1. Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer.
Guo CC; Majewski T; Zhang L; Yao H; Bondaruk J; Wang Y; Zhang S; Wang Z; Lee JG; Lee S; Cogdell D; Zhang M; Wei P; Grossman HB; Kamat A; Duplisea JJ; Ferguson JE; Huang H; Dadhania V; Gao J; Dinney C; Weinstein JN; Baggerly K; McConkey D; Czerniak B
Cell Rep; 2019 May; 27(6):1781-1793.e4. PubMed ID: 31067463
[TBL] [Abstract][Full Text] [Related]
2. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R
Urol Oncol; 2019 Nov; 37(11):826-836. PubMed ID: 31585777
[TBL] [Abstract][Full Text] [Related]
3. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R
Urol Oncol; 2019 Sep; 37(9):573.e19-573.e29. PubMed ID: 31358384
[TBL] [Abstract][Full Text] [Related]
4. Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.
Guo CC; Dadhania V; Zhang L; Majewski T; Bondaruk J; Sykulski M; Wronowska W; Gambin A; Wang Y; Zhang S; Fuentes-Mattei E; Kamat AM; Dinney C; Siefker-Radtke A; Choi W; Baggerly KA; McConkey D; Weinstein JN; Czerniak B
Eur Urol; 2016 Oct; 70(4):611-620. PubMed ID: 26988609
[TBL] [Abstract][Full Text] [Related]
5. Invasive urothelial carcinoma with chordoid features may be an ominous sign predicting sarcomatoid change: a case report of a bladder carcinoma.
Tajima S; Suzuki T; Yamada Y; Morikawa T; Minagawa D; Homma Y; Fukayama M
Med Mol Morphol; 2016 Sep; 49(3):182-7. PubMed ID: 25690253
[TBL] [Abstract][Full Text] [Related]
6. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression.
Braicu C; Buiga R; Cojocneanu R; Buse M; Raduly L; Pop LA; Chira S; Budisan L; Jurj A; Ciocan C; Magdo L; Irimie A; Dobrota F; Petrut B; Berindan-Neagoe I
J Exp Clin Cancer Res; 2019 Oct; 38(1):433. PubMed ID: 31665050
[TBL] [Abstract][Full Text] [Related]
7. MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.
Wu CL; Ho JY; Chou SC; Yu DS
Oncotarget; 2016 May; 7(18):26593-603. PubMed ID: 27058893
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
Xue M; Pang H; Li X; Li H; Pan J; Chen W
Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA circMTO1 suppresses bladder cancer metastasis by sponging miR-221 and inhibiting epithelial-to-mesenchymal transition.
Li Y; Wan B; Liu L; Zhou L; Zeng Q
Biochem Biophys Res Commun; 2019 Jan; 508(4):991-996. PubMed ID: 30551873
[TBL] [Abstract][Full Text] [Related]
11. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
12. Integrative Analysis of Genomic and Clinical Data Reveals Intrinsic Characteristics of Bladder Urothelial Carcinoma Progression.
Zhou B; Guo R
Genes (Basel); 2019 Jun; 10(6):. PubMed ID: 31212967
[TBL] [Abstract][Full Text] [Related]
13. Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer.
Ochoa AE; Choi W; Su X; Siefker-Radtke A; Czerniak B; Dinney C; McConkey DJ
Oncotarget; 2016 Dec; 7(49):80164-80174. PubMed ID: 27845906
[TBL] [Abstract][Full Text] [Related]
14. Nkx2.8 Inhibits Epithelial-Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of
Yu C; Liu Z; Chen Q; Li Y; Jiang L; Zhang Z; Zhou F
Cancer Res; 2018 Mar; 78(5):1241-1252. PubMed ID: 29311157
[TBL] [Abstract][Full Text] [Related]
15. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
16. Progression-associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesis.
Fontugne J; Wong J; Cabel L; Neyret-Kahn H; Karboul N; Maillé P; Rapinat A; Gentien D; Nicolas A; Baulande S; Sibony M; Bernard-Pierrot I; Radvanyi F; Allory Y
J Pathol; 2023 Apr; 259(4):455-467. PubMed ID: 36695554
[TBL] [Abstract][Full Text] [Related]
17. BMP4 Induces M2 Macrophage Polarization and Favors Tumor Progression in Bladder Cancer.
Martínez VG; Rubio C; Martínez-Fernández M; Segovia C; López-Calderón F; Garín MI; Teijeira A; Munera-Maravilla E; Varas A; Sacedón R; Guerrero F; Villacampa F; de la Rosa F; Castellano D; López-Collazo E; Paramio JM; Vicente Á; Dueñas M
Clin Cancer Res; 2017 Dec; 23(23):7388-7399. PubMed ID: 28928159
[No Abstract] [Full Text] [Related]
18. ARID1A alteration in aggressive urothelial carcinoma and variants of urothelial carcinoma.
Li J; Lu S; Lombardo K; Monahan R; Amin A
Hum Pathol; 2016 Sep; 55():17-23. PubMed ID: 27137986
[TBL] [Abstract][Full Text] [Related]
19. Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer.
Garg M
Cancer Metastasis Rev; 2015 Dec; 34(4):691-701. PubMed ID: 26328525
[TBL] [Abstract][Full Text] [Related]
20. Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer.
Yang G; Bondaruk J; Cogdell D; Wang Z; Lee S; Lee JG; Zhang S; Choi W; Wang Y; Liang Y; Wang G; Wang Y; Yao H; Dadhania V; Gao J; Logothetis C; Siefker-Radtke A; Kamat A; Dinney C; Theodorescu D; Kimmel M; Wei P; Guo CC; Weinstein JN; McConkey DJ; Czerniak B
iScience; 2020 Jun; 23(6):101201. PubMed ID: 32521509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
